Podcast Episodes
Back to SearchThe Last Word on JAK Inhibitor Safety and 1133 Study (1.28.2022)
Episode 868
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com
Check out RheumNow.Live
4 years, 4 months ago
Believing is Doing (1.21.2022)
Episode 867
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com. These reports are about better outcomes in Lupus; Less Gout …
4 years, 4 months ago
The Overpricing of Drugs (1.14.2022)
Episode 866
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com
RheumNow.Live is March 19, 20th in Dallas, TX
4 years, 4 months ago
Comorbidities in axSpA- A Focus on Cardiovascular Features Sponsored by Novartis Medical Affairs
Episode 865
Patients with axial spondyloarthritis (axSpA) commonly experience cardiovascular (CV) comorbidities. There is a need to holistically assess a patient…
4 years, 4 months ago
2021 Rheumatology Year in Review (1.7.2022)
Episode 864
Dr. Jack Cush recants the top stories and changes for the field of rheumatology in 2021.
4 years, 4 months ago
Best of 2021 -Jack of All Subspecialties (12.31.2021)
Episode 863
New to RheumNow?
Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheuma…
4 years, 5 months ago
My Podcast Gift (12.24.2021)
Episode 862
Merry Christmas and Happy Holidays from RheumNow. Dr. Jack Cush tells his podcast story - the genesis, keys to success and recommendations on how to…
4 years, 5 months ago
Indications Awaiting (12.17.21)
Episode 861
Dr Jack Cush reviews the latest news, journal reports, regulatory approvals, plus 3 new cases from rheumatologists.
4 years, 5 months ago
Women Leaders in Rheumatology
Episode 860
A moderated panel of prominent female rheumatologists will discuss the challenges and successes in clinical practice and research that they encounter…
4 years, 5 months ago
Juvenile Psoriatic Arthritis and Enthesitis-Related Arthritis
Episode 859
There is a significant burden of disease associated with JPsA and ERA, with patients experiencing structural damage progression, risk of disability, …
4 years, 5 months ago